Glycemic Management
Statement outlines strategies for recovery after exercise in type 1 diabetes
Adults with type 1 diabetes should take several key steps to optimize recovery after exercise, such as adjusting insulin dosing and protein and carbohydrate intake, and carefully monitoring blood glucose, according to a consensus statement.
High-dose vitamin D fails to improve cardiometabolic biomarkers
High-dose vitamin D supplementation did not have beneficial effects on biomarkers of glycemia, inflammation, neurohormonal activation or lipid status, according to new data from the DAYLIGHT trial.
Baseline time in range predicts artificial pancreas success for children with diabetes
A higher baseline time in range is the strongest predictor of glucose response with a closed-loop insulin delivery system for children with type 1 diabetes, according to data published in Diabetes Technology & Therapeutics.
BLOG: Daylight saving time and insulin pump clocks
After a very long year, it is once again time to spring forward for the daylight saving time change, coming up this Sunday, March 14, at 2 a.m.
SGLT2 inhibitors not cost-effective for glycemic management alone in type 2 diabetes
SGLT2 inhibitors provide limited glycemic management benefits and may not be cost-effective for most people with type 2 diabetes, according to a study published in the Journal of Diabetes and Its Complications.
Top in cardiology: High glycemic diet elevates CVD, benefits of ketosis
Data from the PURE study revealed that a diet consisting of high amounts of poor-quality carbohydrates, such as white bread, rice and potatoes, negatively impacts peoples’ health. It was the top story in cardiology last week.
Diets with high glycemic index tied to elevated CVD, mortality risk
Eating a diet with a high glycemic index was associated with elevated risk for CVD and mortality, according to new data from the PURE study published in The New England Journal of Medicine.
Meeting the challenge of caring for older adults living with diabetes
In this issue, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Kathy W. Warwick, RD, CDCES, about special considerations when working with older adults with diabetes.
CGM users see more time in range during early weeks of COVID-19 pandemic
Most people with diabetes who used continuous glucose monitoring during the first 8 weeks of the COVID-19 pandemic improved their time in range, although the benefits varied by region and socioeconomic status, according to study data.
Switch from intermittently scanned to real-time CGM a ‘therapeutic option’
Adults with type 1 diabetes had improvements in glycemic control after switching from an intermittently scanned continuous glucose monitor to a real-time CGM, according to a study published in Diabetes Technology & Therapeutics.